Literature DB >> 17609280

Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006.

J Joukje Siebenga1, Harry Vennema, Bernadet Renckens, Erwin de Bruin, Bas van der Veer, Roland J Siezen, Marion Koopmans.   

Abstract

Noroviruses are the causative agents of the majority of viral gastroenteritis outbreaks in humans. During the past 15 years, noroviruses of genotype GGII.4 have caused four epidemic seasons of viral gastroenteritis, during which four novel variants (termed epidemic variants) emerged and displaced the resident viruses. In order to understand the mechanisms and biological advantages of these epidemic variants, we studied the genetic changes in the capsid proteins of GGII.4 strains over this period. A representative sample was drawn from 574 GGII.4 outbreak strains collected over 15 years of systematic surveillance in The Netherlands, and capsid genes were sequenced for a total of 26 strains. The three-dimensional structure was predicted by homology modeling, using the Norwalk virus (Hu/NoV/GGI.1/Norwalk/1968/US) capsid as a reference. The highly significant preferential accumulation and fixation of mutations (nucleotide and amino acid) in the protruding part of the capsid protein provided strong evidence for the occurrence of genetic drift and selection. Although subsequent new epidemic variants differed by up to 25 amino acid mutations, consistent changes were observed in only five positions. Phylogenetic analyses showed that each variant descended from its chronologic predecessor, with the exception of the 2006b variant, which is more closely related to the 2002 variant than to the 2004 variant. The consistent association between the observed genetic findings and changes in epidemiology leads to the conclusion that population immunity plays a role in the epochal evolution of GGII.4 norovirus strains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609280      PMCID: PMC2045401          DOI: 10.1128/JVI.00674-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002.

Authors:  Marc-Alain Widdowson; Elaine H Cramer; Leslie Hadley; Joseph S Bresee; R Suzanne Beard; Sandra N Bulens; Myrna Charles; Wairimu Chege; Elmira Isakbaeva; Jennifer G Wright; Eric Mintz; David Forney; Jeffrey Massey; Roger I Glass; Stephan S Monroe
Journal:  J Infect Dis       Date:  2004-06-08       Impact factor: 5.226

2.  Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s.

Authors:  Leo M Schouls; Han G J van der Heide; Luc Vauterin; Paul Vauterin; Frits R Mooi
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

3.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

4.  E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability.

Authors:  Ming Tan; Weiming Zhong; Dan Song; Scott Thornton; Xi Jiang
Journal:  J Med Virol       Date:  2004-12       Impact factor: 2.327

5.  Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers.

Authors:  R G Wyatt; R Dolin; N R Blacklow; H L DuPont; R F Buscho; T S Thornhill; A Z Kapikian; R M Chanock
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

6.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults.

Authors:  P C Johnson; J J Mathewson; H L DuPont; H B Greenberg
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

7.  Clinical immunity in acute gastroenteritis caused by Norwalk agent.

Authors:  T A Parrino; D S Schreiber; J S Trier; A Z Kapikian; N R Blacklow
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

8.  Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH).

Authors:  Chris I Gallimore; David Lewis; Clive Taylor; Andrew Cant; Andrew Gennery; Jim J Gray
Journal:  J Clin Virol       Date:  2004-06       Impact factor: 3.168

9.  Inter- and intragenus structural variations in caliciviruses and their functional implications.

Authors:  Rong Chen; John D Neill; Jacqueline S Noel; Anne M Hutson; Roger I Glass; Mary K Estes; B V Venkataram Prasad
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity.

Authors:  Robert C Edgar
Journal:  BMC Bioinformatics       Date:  2004-08-19       Impact factor: 3.169

View more
  167 in total

1.  Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan.

Authors:  Kazushi Motomura; Masaru Yokoyama; Hirotaka Ode; Hiromi Nakamura; Hiromi Mori; Tadahito Kanda; Tomoichiro Oka; Kazuhiko Katayama; Mamoru Noda; Tomoyuki Tanaka; Naokazu Takeda; Hironori Sato
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  The effects of a deleterious mutation load on patterns of influenza A/H3N2's antigenic evolution in humans.

Authors:  Katia Koelle; David A Rasmussen
Journal:  Elife       Date:  2015-09-15       Impact factor: 8.140

4.  Structural Evolution of the Emerging 2014-2015 GII.17 Noroviruses.

Authors:  Bishal Kumar Singh; Anna Koromyslova; Lisa Hefele; Clara Gürth; Grant S Hansman
Journal:  J Virol       Date:  2015-12-23       Impact factor: 5.103

5.  Molecular epidemiology of oyster-related human noroviruses and their global genetic diversity and temporal-geographical distribution from 1983 to 2014.

Authors:  Yongxin Yu; Hui Cai; Linghao Hu; Rongwei Lei; Yingjie Pan; Shuling Yan; Yongjie Wang
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

Review 6.  Burden of norovirus in healthcare facilities and strategies for outbreak control.

Authors:  A Kambhampati; M Koopmans; B A Lopman
Journal:  J Hosp Infect       Date:  2015-02-04       Impact factor: 3.926

7.  Genetic diversity among food-borne and waterborne norovirus strains causing outbreaks in Sweden.

Authors:  Maria Lysén; Margareta Thorhagen; Maria Brytting; Marika Hjertqvist; Yvonne Andersson; Kjell-Olof Hedlund
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

8.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.

Authors:  Jennifer L Cannon; Lisa C Lindesmith; Eric F Donaldson; Lauryn Saxe; Ralph S Baric; Jan Vinjé
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 10.  Learning from nature - novel synthetic biology approaches for biomaterial design.

Authors:  Anton V Bryksin; Ashley C Brown; Michael M Baksh; M G Finn; Thomas H Barker
Journal:  Acta Biomater       Date:  2014-01-24       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.